CLINICAL TRIALS PROFILE FOR ZEMDRI
✉ Email this page to a colleague
All Clinical Trials for zemdri
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT04699656 ↗ | Plazomicin Study in ESRD Patients Receiving IHD | Completed | Cipla USA Inc. | Phase 1 | 2021-01-05 | This study is being conducted to directly characterize the pharmacokinetic (PK) profile of plazomicin following administration of a single oral dose before and after IHD in subjects with ESRD. This PK assessment will be used to provide appropriate plazomicin dosing recommendations for patients with ESRD receiving IHD. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for zemdri
Condition Name
Clinical Trial Locations for zemdri
Trials by Country
Clinical Trial Progress for zemdri
Clinical Trial Phase
Clinical Trial Sponsors for zemdri
Sponsor Name